Vertex Pharmaceuticals · Depreciation & Amortization

Latest reported$222.10Mperiod endingJun 30, 2026

VRTX Depreciation & Amortization ($1.80M → $222.10M)

Annual Depreciation & Amortization

High-resolution chart · PNG

VRTX depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	209,800,000
Dec 31, 2024	207,200,000
Dec 31, 2023	181,300,000
Dec 31, 2022	148,300,000
Dec 31, 2021	125,600,000
Dec 31, 2020	109,515,000
Dec 31, 2019	106,941,000
Dec 31, 2018	72,420,000
Dec 31, 2017	61,397,000
Dec 31, 2016	61,398,000
Dec 31, 2015	62,343,000
Dec 31, 2014	63,257,000
Dec 31, 2013	48,365,000
Dec 31, 2012	38,191,000
Dec 31, 2011	35,041,000
Dec 31, 2010	30,459,000
Dec 31, 2009	30,107,000
Dec 31, 2008	32,196,000
Dec 31, 2007	27,459,000
Dec 31, 2006	25,868,000
Dec 31, 2005	27,289,000
Dec 31, 2004	29,640,000
Dec 31, 2003	23,438,000
Dec 31, 2002	25,432,000
Dec 31, 2001	17,964,000
Dec 31, 2000	9,095,000
Dec 31, 1999	6,300,000
Dec 31, 1998	4,500,000
Dec 31, 1997	3,600,000
Dec 31, 1996	3,200,000
Dec 31, 1995	3,700,000
Dec 31, 1994	3,500,000
Dec 31, 1993	3,900,000
Dec 31, 1992	2,800,000
Dec 31, 1991	1,800,000